Carnitine deficiency in OCTN2-/- newborn mice leads to a severe gut and immune phenotype with widespread atrophy, apoptosis and a pro-inflammatory response.
We have investigated the gross, microscopic and molecular effects of carnitine deficiency in the neonatal gut using a mouse model with a loss-of-function mutation in the OCTN2 (SLC22A5) carnitine transporter. The tissue carnitine content of neonatal homozygous (OCTN2(-/-)) mouse small intestine was...
Main Authors: | Srinivas Sonne, Prem S Shekhawat, Dietrich Matern, Vadivel Ganapathy, Leszek Ignatowicz |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3480427?pdf=render |
Similar Items
-
Dual targeting of l-carnitine-conjugated nanoparticles to OCTN2 and ATB0,+ to deliver chemotherapeutic agents for colon cancer therapy
by: Longfa Kou, et al.
Published: (2017-01-01) -
Residual OCTN2 transporter activity, carnitine levels and symptoms correlate in patients with primary carnitine deficiency
by: Jan Rasmussen, et al.
Published: (2014-01-01) -
Acute Exercise Stimulates Carnitine Biosynthesis and OCTN2 Expression in Mouse Kidney
by: Tom L. Broderick, et al.
Published: (2017-06-01) -
Different involvement of promoter methylation in the expression of organic cation/carnitine transporter 2 (OCTN2) in cancer cell lines.
by: Qiang Qu, et al.
Published: (2013-01-01) -
Neonatal screening of a mutation (R254X) of SLC22A5 (OCTN2) in Primary Carnitine Deficiency
by: Chiung-Chuan Wu, et al.
Published: (2009)